Jing Rong Jean Cui
Vermogen: 74 M $ op 30-09-2026
Vermogen: 74 M $ op 30-09-2026
Jing Rong Jean Cui is the founder of Blossomhill Therapeutics, Inc., founded in 2020.
Dr. Jean Cui was the founder of Turning Point Therapeutics, Inc., founded in 2013, and held the title of Director in 2020.
Dr. Jean Cui earned a doctorate from The Ohio State University.
Dr. Jean Cui completed undergraduate and graduate degrees at the University of Science & Technology of China.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-08-2026 | 3.973.138 ( 12,5% ) | 74 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Oprichter | 01-06-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TURG POIN | Oprichter | 15-06-2020 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau